SRS Capital Advisors Inc. boosted its holdings in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 0.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 19,587 shares of the medical technology company’s stock after purchasing an additional 60 shares during the period. SRS Capital Advisors Inc.’s holdings in Teleflex were worth $4,844,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently added to or reduced their stakes in the company. Cromwell Holdings LLC lifted its stake in shares of Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after buying an additional 49 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in shares of Teleflex during the 3rd quarter worth approximately $40,000. GAMMA Investing LLC grew its position in shares of Teleflex by 131.1% in the third quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock valued at $42,000 after purchasing an additional 97 shares in the last quarter. Canada Pension Plan Investment Board acquired a new stake in shares of Teleflex in the second quarter valued at approximately $42,000. Finally, Versant Capital Management Inc increased its stake in shares of Teleflex by 20,700.0% in the 2nd quarter. Versant Capital Management Inc now owns 208 shares of the medical technology company’s stock worth $44,000 after acquiring an additional 207 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on TFX. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a report on Tuesday. Stephens lifted their target price on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a report on Friday, November 1st. Mizuho reduced their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Finally, Royal Bank of Canada dropped their price target on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Teleflex has a consensus rating of “Moderate Buy” and an average target price of $259.25.
Teleflex Stock Up 0.9 %
NYSE:TFX traded up $1.71 during midday trading on Friday, reaching $192.15. The company had a trading volume of 515,661 shares, compared to its average volume of 378,038. Teleflex Incorporated has a 12-month low of $189.95 and a 12-month high of $257.85. The firm has a market capitalization of $8.92 billion, a price-to-earnings ratio of 38.20, a PEG ratio of 1.99 and a beta of 1.18. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock’s fifty day simple moving average is $230.35 and its 200-day simple moving average is $223.19.
Teleflex (NYSE:TFX – Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping the consensus estimate of $3.38 by $0.11. The company had revenue of $764.40 million during the quarter, compared to analysts’ expectations of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm’s revenue was up 2.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $3.64 EPS. On average, sell-side analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.
Teleflex Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.71%. Teleflex’s dividend payout ratio is currently 27.04%.
Teleflex Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
See Also
- Five stocks we like better than Teleflex
- Golden Cross Stocks: Pattern, Examples and Charts
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.